Literature DB >> 10866875

Do statins prevent both cardiovascular disease and fracture?

S R Cummings, D C Bauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10866875     DOI： 10.1001/jama.283.24.3255

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Authors:  D C Bauer
Journal:  Osteoporos Int       Date:  2003-05-08       Impact factor: 4.507

2.  Metabolic and structural bone disturbances induced by hyperlipidic diet in mice treated with simvastatin.

Authors:  Evelise Aline Soares; Rômulo Dias Novaes; Wilson Romero Nakagaki; Geraldo José Medeiros Fernandes; José Antônio Dias Garcia; José Angelo Camilli
Journal:  Int J Exp Pathol       Date:  2015-07-14       Impact factor: 1.925

Review 3.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.

Authors:  Jessica M Peña; Sara Aspberg; Jean MacFadyen; Robert J Glynn; Daniel H Solomon; Paul M Ridker
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

5.  Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women.

Authors:  Pilar Orozco
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 6.  Statins, hormones, and women: benefits and drawbacks for atherosclerosis and osteoporosis.

Authors:  D M Herrington; K Potvin Klein
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

7.  Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2010-05-20

8.  Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

Authors:  Heiner K Berthold; Susanne Unverdorben; Armin Zittermann; Ralf Degenhardt; Bernhard Baumeister; Martin Unverdorben; Wilhelm Krone; Hans Vetter; Ioanna Gouni-Berthold
Journal:  Osteoporos Int       Date:  2004-02-14       Impact factor: 4.507

Review 9.  HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

Authors:  Raymond G Schlienger; Christoph R Meier
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Does simvastatin stimulate bone formation in vivo?

Authors:  Dietrich von Stechow; Susan Fish; Dror Yahalom; Itai Bab; Michael Chorev; Ralph Müller; Joseph M Alexander
Journal:  BMC Musculoskelet Disord       Date:  2003-04-28       Impact factor: 2.362
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.